Proton pump inhibitors in prevention of cisplatin-induced nephrotoxicity: a systematic review
Authors:
- Sina PakkhesalSPSina Pakkhesal
- Pouya MohammadiPMPouya Mohammadi
- Afra RezagholizadehARAfra Rezagholizadeh
- Zahra KoochakiZKZahra Koochaki
- Mohammad Amin RamezaniMRMohammad Amin Ramezani
- Amirhossein AzampourAAAmirhossein Azampour
- Mahyar KhederbaigiMKMahyar Khederbaigi
- Sajad KhialiSKSajad Khiali
- Afshin GharekhaniAGAfshin Gharekhani
- 4 November 2026
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (11) , 1191
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Intravenous Magnesium and Cisplatin-Associated Acute Kidney InjuryJAMA Oncology, 2025
- Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort studyInternational Journal of Cancer, 2023
- Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitorsInternational Journal of Cancer, 2021
- Cisplatin‐induced nephrotoxicity in an outpatient settingPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in ratsBiopharmaceutics & Drug Disposition, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Proton Pump Inhibitor Use and the Risk of Chronic Kidney DiseaseJAMA Internal Medicine, 2016
- Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trialCancer Chemotherapy and Pharmacology, 2003
- Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and OrmaplatinGynecologic Oncology, 1993
- Nephrotoxicity of cis‐platinum (II) dichlorodiammineClinical Pharmacology & Therapeutics, 1978